PARP1 inhibitor eliminated imatinib-refractory chronic myeloid leukemia cells in bone marrow microenvironment conditions.

作者: Paulina Podszywalow-Bartnicka , Silvia Maifrede , Bac Viet Le , Margaret Nieborowska-Skorska , Katarzyna Piwocka

DOI: 10.1080/10428194.2018.1471602

关键词:

摘要: Treatment with tyrosine kinase inhibitors (TKIs) results in remission and prolongation of survival, but fails to eliminate the leukemia stem cells (LSCs) responsible for disease development pro...

参考文章(14)
Puneet Agarwal, Ravi Bhatia, Influence of Bone Marrow Microenvironment on Leukemic Stem Cells: Breaking Up an Intimate Relationship. Advances in Cancer Research. ,vol. 127, pp. 227- 252 ,(2015) , 10.1016/BS.ACR.2015.04.007
King Pan Ng, Aditi Manjeri, Kian Leong Lee, Weijie Huang, Soo Yong Tan, Charles T. H. Chuah, Lorenz Poellinger, S. Tiong Ong, Physiologic hypoxia promotes maintenance of CML stem cells despite effective BCR-ABL1 inhibition. Blood. ,vol. 123, pp. 3316- 3326 ,(2011) , 10.1182/BLOOD-2013-07-511907
Eric Deutsch, Sylvie Jarrousse, Dorothée Buet, Aymeric Dugray, Marie-Laure Bonnet, Marie-Catherine Vozenin-Brotons, François Guilhot, Ali G. Turhan, Jean Feunteun, Jean Bourhis, Down-regulation of BRCA1 in BCR-ABL-expressing hematopoietic cells Blood. ,vol. 101, pp. 4583- 4588 ,(2003) , 10.1182/BLOOD-2002-10-3011
Mateusz Koptyra, Rafal Falinski, Michal O Nowicki, Tomasz Stoklosa, Ireneusz Majsterek, Margaret Nieborowska-Skorska, Janusz Blasiak, Tomasz Skorski, None, BCR/ABL kinase induces self-mutagenesis via reactive oxygen species to encode imatinib resistance Blood. ,vol. 108, pp. 319- 327 ,(2006) , 10.1182/BLOOD-2005-07-2815
Elisabeth Bolton-Gillespie, Mirle Schemionek, Hans-Ulrich Klein, Sylwia Flis, Grazyna Hoser, Thoralf Lange, Margaret Nieborowska-Skorska, Jacqueline Maier, Linda Kerstiens, Mateusz Koptyra, Martin C. Müller, Hardik Modi, Tomasz Stoklosa, Ilona Seferynska, Ravi Bhatia, Tessa L. Holyoake, Steffen Koschmieder, Tomasz Skorski, Genomic instability may originate from imatinib-refractory chronic myeloid leukemia stem cells. Blood. ,vol. 121, pp. 4175- 4183 ,(2013) , 10.1182/BLOOD-2012-11-466938
Paulina Podszywalow-Bartnicka, Magdalena Wolczyk, Monika Kusio-Kobialka, Kamila Wolanin, Krzysztof Skowronek, Margaret Nieborowska-Skorska, Yashodhara Dasgupta, Tomasz Skorski, Katarzyna Piwocka, Downregulation of BRCA1 protein in BCR-ABL1 leukemia cells depends on stress-triggered TIAR-mediated suppression of translation Cell Cycle. ,vol. 13, pp. 3727- 3741 ,(2014) , 10.4161/15384101.2014.965013
Eric Deutsch, Aymeric Dugray, Bassam AbdulKarim, Elisabetta Marangoni, Laurence Maggiorella, Sabine Vaganay, Radia M'Kacher, Setha Douc Rasy, François Eschwege, William Vainchenker, Ali G. Turhan, Jean Bourhis, BCR-ABL down-regulates the DNA repair protein DNA-PKcs. Blood. ,vol. 97, pp. 2084- 2090 ,(2001) , 10.1182/BLOOD.V97.7.2084
Norman Chan, Isabel M. Pires, Zuzana Bencokova, Carla Coackley, Kaisa R. Luoto, Nirmal Bhogal, Minalini Lakshman, Ponnari Gottipati, F. Javier Oliver, Thomas Helleday, Ester M. Hammond, Robert G. Bristow, Contextual Synthetic Lethality of Cancer Cell Kill Based on the Tumor Microenvironment Cancer Research. ,vol. 70, pp. 8045- 8054 ,(2010) , 10.1158/0008-5472.CAN-10-2352
F. Vianello, F. Villanova, V. Tisato, S. Lymperi, K.-K. Ho, A. R. Gomes, D. Marin, D. Bonnet, J. Apperley, E. W.- F. Lam, F. Dazzi, Bone marrow mesenchymal stromal cells non-selectively protect chronic myeloid leukemia cells from imatinib-induced apoptosis via the CXCR4/CXCL12 axis Haematologica. ,vol. 95, pp. 1081- 1089 ,(2010) , 10.3324/HAEMATOL.2009.017178